Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates

Shepherd, 1995, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia, New Engl. J. Med., 333, 1301, 10.1056/NEJM199511163332001 1994, Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet, 344, 1383 Sacks, 1996, For the cholesterol and recurrent event trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, New Engl. J. Med., 335, 1001, 10.1056/NEJM199610033351401 Downs, 1998, Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels, J. Am. Med. Assoc., 279, 1615, 10.1001/jama.279.20.1615 Bocan, 1992, Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors, Biochim. Biophys. Acta, 1123, 133, 10.1016/0005-2760(92)90103-3 Nawrocki, 1995, Reduction of LDL cholesterol by 25 to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor, Arterioscler. Thromb. Vasc. Biol., 15, 678, 10.1161/01.ATV.15.5.678 Huff, 1997, 3-hydroxy-3-methylglutaryl coenzyme A inhibitors and hepatic apolipoprotein B secretion, Curr. Opin. Lipidol., 8, 138, 10.1097/00041433-199706000-00003 Burnett, 1997, Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs, Arterioscler. Thromb. Vasc. Biol., 17, 2589, 10.1161/01.ATV.17.11.2589 Krause, 1995, Lipid-lowering activity of atorvastatin in rodent species: triglyceride-lowering in rats predicts efficacy in LDL animal models, Atherosclerosis, 117, 237, 10.1016/0021-9150(95)05576-I Vega, 1990, Pravastatin therapy in primary moderate hypercholesterolemia: changes in metabolism of apolipoprotein B-containing lipoproteins, J. Int. Med., 227, 81, 10.1111/j.1365-2796.1990.tb00124.x Arad, 1990, Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production, J. Lipid Res., 30, 567, 10.1016/S0022-2275(20)42825-1 Watts, 1995, Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implication, Eur. J. Clin. Invest., 25, 559, 10.1111/j.1365-2362.1995.tb01746.x Naoumova, 1997, Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin, J. Lipid Res., 38, 1496, 10.1016/S0022-2275(20)37432-0 Packard, 1997, Lipoprotein heterogeneity and apolipoprotein B metabolism, Arterioscler. Thromb. Vasc. Biol., 17, 3542, 10.1161/01.ATV.17.12.3542 Lipid Research Clinics Program Manual of Laboratory Operations. DHEW Publications 1975; No. (NIH) 75–628, Washington, DC. Havekes, 1987, A rapid micromethod for apolipoprotein E phenotyping directly in serum, J. Lipid Res., 28, 455, 10.1016/S0022-2275(20)38697-1 Lindgren, 1972, The isolation and quantitation analysis of serum lipoproteins, 181 Griffin, 1990, Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation, Atherosclerosis, 83, 59, 10.1016/0021-9150(90)90131-2 Demant, 1996, Sensitive methods to study human apolipoprotein B metabolism using stable isotope-labeled amino acids, Am. J. Physiol., 270, E1022 Egusa, 1983, Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B, J. Lipid Res., 24, 1261, 10.1016/S0022-2275(20)37908-6 Demant, 1994, A sensitive mass spectrometry technique for the measurement of human apolipoprotein B metabolism in vivo, Clin. Chem., 40, 1825, 10.1093/clinchem/40.9.1825 Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Packard, 2000, Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions, J. Lipid Res., 41, 305, 10.1016/S0022-2275(20)32065-4 Tan, 1995, Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfractions in normolipemic men and women, Arterioscler. Thromb. Vasc. Biol., 15, 1839, 10.1161/01.ATV.15.11.1839 Stalenhoef, 1984, Metabolism of apolipoproteins B48 and B100 of triglyceride rich lipoproteins in normal and lipoprotein lipase deficient humans, Proc. Natl. Acad. Sci. USA, 81, 1837, 10.1073/pnas.81.6.1839 Gaw, 1993, Effects of simvastatin on apoB metabolism and LDL subfraction distribution, Arterioscler. Thromb., 13, 170, 10.1161/01.ATV.13.2.170 Parhofer, 1993, Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia, Clin. Invest., 71, 939, 10.1007/BF00185608 Chan, 2000, Effects of atorvastatin on apolipoprotein B kinetics in viscerol obesity, Atherosclerosis, 151, 95, 10.1016/S0021-9150(00)80429-3 Cuchel, 1997, Lovastatin decreased de novo cholesterol synthesis and LDL apoB-100 production rates in combined hyperlipidemic males, Arterioscler. Thromb. Vasc. Biol., 17, 1910, 10.1161/01.ATV.17.10.1910 Stein, 1998, Comparison of statins in hypertriglyceridemia, Am J. Cardiol., 81, 66B, 10.1016/S0002-9149(98)00041-1 Gianturco, 1982, Receptor mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts, J. Lipid Res., 23, 984, 10.1016/S0022-2275(20)38070-6 Cianflone, 1990, Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesterol ester synthesis in the response to a fatty acid challenge, J. Lipid Res., 31, 2045, 10.1016/S0022-2275(20)42269-2 Kasim, 1993, Effect of lovastatin on the secretion of very low density lipoprotein lipids and apolipoprotein B in the hypertriglyceridemic Zucker obese rat, Atherosclerosis, 104, 147, 10.1016/0021-9150(93)90185-W Mohammadi, 1998, Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells, Arterioscler. Thromb. Vasc. Biol., 18, 783, 10.1161/01.ATV.18.5.783 Aguilar-Salinas, 1997, A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism: kinetics of apolipoprotein B during placebo and pravastatin therapy, Arterioscler. Thromb. Vasc. Biol., 17, 72, 10.1161/01.ATV.17.1.72 Berglund, 1998, Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach, J. Lipid Res., 39, 913, 10.1016/S0022-2275(20)32577-3 Kervinen, 1993, Lovastatin enhances hepatic uptake of low density lipoprotein in humans, J. Lipid Res., 34, 1975, 10.1016/S0022-2275(20)35115-4 Gianturco, 1993, Effects of lovastatin on the levels, structure and atherogenicity of VLDL in patients with moderate hypertriglyceridemia, Arterioscler. Thromb., 13, 472, 10.1161/01.ATV.13.4.472